Immunoadsorption in patients with haemolytic uraemic syndrome
- 17 February 2012
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 379 (9815), 517-518
- https://doi.org/10.1016/s0140-6736(12)60228-1
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in GermanyNew England Journal of Medicine, 2011
- Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trialThe Lancet, 2011
- Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological studyThe Lancet Infectious Diseases, 2011
- Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011Eurosurveillance, 2011